FDA Drug Application (011721) for NEPTAZANE by LEDERLE

Back to FDA Applications sponsored by LEDERLE

Application Number011721
Product Number001
FormTABLET;ORAL
Dosage50MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNEPTAZANE
Active IngredientMETHAZOLAMIDE

Active IngredientCount
List of drugs with Active Ingredient METHAZOLAMIDE2


Back to FDA Applications sponsored by LEDERLE